• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Within-person stability of lipoprotein(a) concentration.

作者信息

Ghouse Jonas, Ahlberg Gustav, Albertsen Rand Søren, Salling Olesen Morten, Vilhjalmsson Bjarni, Stender Stefan, Bundgaard Henning

机构信息

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100 Copenhagen, Denmark.

Cardiac Genetics Group, Department of Biomedical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.

出版信息

Eur Heart J. 2025 Mar 24;46(12):1159-1161. doi: 10.1093/eurheartj/ehae652.

DOI:10.1093/eurheartj/ehae652
PMID:39375838
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11931201/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f636/11931201/062f172a5670/ehae652f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f636/11931201/062f172a5670/ehae652f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f636/11931201/062f172a5670/ehae652f1.jpg

相似文献

1
Within-person stability of lipoprotein(a) concentration.脂蛋白(a)浓度的个体内稳定性。
Eur Heart J. 2025 Mar 24;46(12):1159-1161. doi: 10.1093/eurheartj/ehae652.
2
Short-term intraindividual variability in lipoprotein measurements: the Atherosclerosis Risk in Communities (ARIC) Study.
Am J Epidemiol. 1992 Nov 1;136(9):1069-81. doi: 10.1093/oxfordjournals.aje.a116572.
3
Repeat Measures of Lipoprotein(a) Molar Concentration and Cardiovascular Risk.脂蛋白(a)摩尔浓度的重复测量与心血管风险。
J Am Coll Cardiol. 2022 Feb 22;79(7):617-628. doi: 10.1016/j.jacc.2021.11.055.
4
Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.基因水平升高的脂蛋白(a)与心肌梗死风险增加
JAMA. 2009 Jun 10;301(22):2331-9. doi: 10.1001/jama.2009.801.
5
Greater variability in lipid measurements associated with kidney diseases in patients with type 2 diabetes mellitus in a 10-year diabetes cohort study.在一项为期 10 年的糖尿病队列研究中，2 型糖尿病患者的肾脏疾病与血脂测量的变异性更大相关。
Sci Rep. 2021 Apr 13;11(1):8047. doi: 10.1038/s41598-021-87067-4.
6
Measurement issues related to lipoprotein heterogeneity.与脂蛋白异质性相关的测量问题。
Am J Cardiol. 2002 Oct 17;90(8A):22i-29i. doi: 10.1016/s0002-9149(02)02632-2.
7
Intrapersonal Stability of Plasma Metabolomic Profiles over 10 Years among Women.女性血浆代谢组学图谱十年间的个体内稳定性
Metabolites. 2022 Apr 20;12(5):372. doi: 10.3390/metabo12050372.
8
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.脂蛋白(a)浓度与冠心病、中风及非血管性死亡风险
JAMA. 2009 Jul 22;302(4):412-23. doi: 10.1001/jama.2009.1063.
9
Biological variability of cholesterol, triglyceride, low- and high-density lipoprotein cholesterol, lipoprotein(a), and apolipoproteins A-I and B.胆固醇、甘油三酯、低密度和高密度脂蛋白胆固醇、脂蛋白(a)以及载脂蛋白A-I和B的生物学变异性。
Clin Chem. 1994 Apr;40(4):574-8.
10
Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Impact on the assessment of risk according to the National Cholesterol Education Program guidelines.
Arch Intern Med. 1990 Aug;150(8):1653-7.

引用本文的文献

1
Lp(a): Global Public Health Concern: Emerging Knowledge and Therapeutic Approaches.脂蛋白(a)：全球公共卫生关注点——新认知与治疗方法
Curr Cardiol Rep. 2025 Jun 25;27(1):104. doi: 10.1007/s11886-025-02255-2.
2
[Not Available].[无可用内容]。
Adv Lab Med. 2025 Mar 3;6(1):17-27. doi: 10.1515/almed-2024-0090. eCollection 2025 Mar.
3
Fundamentals of lipoprotein(a) request and quantification in the clinical laboratory.临床实验室中脂蛋白(a)检测与定量的基础

本文引用的文献

1
Temporal Trends in Lipoprotein(a) Concentrations: The Atherosclerosis Risk in Communities Study.脂蛋白(a)浓度的时间趋势：社区动脉粥样硬化风险研究。
J Am Heart Assoc. 2022 Nov;11(21):e026762. doi: 10.1161/JAHA.122.026762. Epub 2022 Oct 26.
2
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.脂蛋白(a)与动脉粥样硬化性心血管疾病及主动脉瓣狭窄：欧洲动脉粥样硬化学会共识声明。
Eur Heart J. 2022 Oct 14;43(39):3925-3946. doi: 10.1093/eurheartj/ehac361.
3
Repeat Measures of Lipoprotein(a) Molar Concentration and Cardiovascular Risk.
Adv Lab Med. 2025 Mar 3;6(1):7-16. doi: 10.1515/almed-2025-0034. eCollection 2025 Mar.
4
Lipoprotein(a) and thromboembolism: current state of knowledge and unsolved issues.脂蛋白(a)与血栓栓塞：当前的知识现状及未解决的问题。
Arch Med Sci. 2024 Dec 13;20(6):1770-1783. doi: 10.5114/aoms/197357. eCollection 2024.
脂蛋白(a)摩尔浓度的重复测量与心血管风险。
J Am Coll Cardiol. 2022 Feb 22;79(7):617-628. doi: 10.1016/j.jacc.2021.11.055.
4
Lp(a) (Lipoprotein[a]) Concentrations and Incident Atherosclerotic Cardiovascular Disease: New Insights From a Large National Biobank.脂蛋白(a)（Lipoprotein[a]）浓度与动脉粥样硬化性心血管疾病的发生：来自大型国家生物库的新见解。
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):465-474. doi: 10.1161/ATVBAHA.120.315291. Epub 2020 Oct 29.
5
Temporal variability in lipoprotein(a) levels in patients enrolled in the placebo arms of IONIS-APO(a) and IONIS-APO(a)-L antisense oligonucleotide clinical trials.在 IONIS-APO(a) 和 IONIS-APO(a)-L 反义寡核苷酸临床试验的安慰剂组中，脂蛋白(a)水平的时间变异性。
J Clin Lipidol. 2018 Jan-Feb;12(1):122-129.e2. doi: 10.1016/j.jacl.2017.10.024. Epub 2017 Nov 2.
6
Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.脂蛋白（a）作为心血管疾病的一个病因：来自流行病学、遗传学和生物学的见解
J Lipid Res. 2016 Nov;57(11):1953-1975. doi: 10.1194/jlr.R071233. Epub 2016 Sep 27.